International Clinical Trial: A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133399) titled 'A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood' on Aug. 19.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Boehringer Ingelheim

Condition: Healthy

Intervention: Drug: vicadrostat / empagliflozin combination 1

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 5, 2025

Target Sam...